Learn More
Medchemexpress LLC (2S,4R)-1-((S)-2-(tert-butyl)-14-(4-(4-((3-chloro-4-((3-fluorobenzyl)oxy)phenyl)amino)quinazolin-6-yl) | 2230821-40-4 | 99.7% | 1074.65 | C57H61ClFN7O9S | 5 MG

Supplier: Medchemexpress LLC HY1318655MG
SJF-1521 is a small-molecule PROTAC degrader that selectively targets epidermal growth factor receptor (EGFR) for proteasomal degradation. It is intended for research applications investigating EGFR signaling, degradation mechanisms, and tumor biology, and is supplied with manufacturer analytical data supporting its characterization.
- Selective EGFR-targeting PROTAC degrader.
- Demonstrated to induce EGFR degradation in OVCAR8 cells.
- High reported purity (≈99.7%).
- Characterized by molecular weight and structural analytical data.
- Supplied in small research quantities suitable for in vitro studies.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.